AMGN Shares Outstanding History
Below is a table of the AMGN shares outstanding history going back to 2/12/2010:

Date AMGN Shares Outstanding
2/12/2010979.30M
5/3/2010957.94M
7/30/2010958.47M
10/29/2010944.82M
2/11/2011932.45M
4/29/2011929.73M
6/30/2011791.43M
7/27/2011924.09M
10/26/2011876.54M
4/26/2012777.71M
7/25/2012770.77M
10/29/2012767.36M
2/19/2013748.43M
4/24/2013749.98M
7/30/2013753.36M
10/22/2013754.13M
2/13/2014755.01M
4/22/2014757.02M
7/29/2014759.61M
10/21/2014760.67M
2/12/2015758.86M
4/20/2015760.32M
7/28/2015758.25M
10/27/2015754.33M
2/9/2016752.09M
4/25/2016751.22M
7/25/2016748.36M
10/24/2016743.92M
2/9/2017736.45M
4/18/2017735.40M
7/18/2017729.67M
10/17/2017725.91M
2/9/2018720.56M
4/18/2018661.71M
7/18/2018647.27M
10/24/2018637.22M
2/7/2019622.28M
4/24/2019609.94M
7/24/2019599.70M
8/30/20199.66M
10/23/2019594.18M
2/6/2020589.81M
4/27/2020588.25M

Also see: AMGN Market Cap History
AMGN YTD Return
AMGN RSI
AMGN DMA
AMGN MACD
AMGN Technical Analysis
AMGN Historical Shares Outstanding:
-4.87% CAGR
AMGN Historical Shares Outstanding: +-4.87% CAGR

Mouse over chart for data details
2/12/2010 ...4/27/2020
Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. We show 43 historical shares outstanding datapoints in our coverage of AMGN's shares outstanding history.

Understanding the changing numbers of AMGN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AMGN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AMGN by allowing them to research AMGN shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AMGN:
AMGN SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Amgen (AMGN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AMN Shares Outstanding History
AMPH Shares Outstanding History
ANAB Shares Outstanding History
ANGO Shares Outstanding History
ANIK Shares Outstanding History
ANIP Shares Outstanding History
ANTH Shares Outstanding History
APEN Shares Outstanding History
APLS Shares Outstanding History
APRI Shares Outstanding History
More Healthcare companies »

 

AMGN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.